{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:35:15Z","timestamp":1785497715252,"version":"3.56.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Sugammadex is a modified gamma-cyclodextrin that acts by selectively encapsulating free amino-steroidal neuromuscular relaxants. Several case reports have been published on the use of sugammadex in patients with neuromuscular disorders that include neuromuscular junction diseases, myopathies, neuropathies, and motor neurone disorders. The primary aim of this review is to systematically review the evidence on the use of sugammadex in patients with this heterogeneous group of diseases and provide recommendations for clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic electronic search of Medline, Embase and CINAHL databases was done until June 2019, to identify case reports describing the use of sugammadex in adult surgical patients with neuromuscular disorders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 578 records identified through database searches, 43 articles were finally included for the systematic review. Of these, 17 reports were on patients with myopathy, 15 reports on myasthenia gravis, 9 reports on motor neuron diseases and 2 reports on neuropathies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Majority of the articles reviewed report successful use of sugammadex to reverse steroidal muscle relaxants, especially rocuronium, in patients with neuromuscular diseases. However, with sugammadex, unpredictability in response and uncertainty regarding optimum dose still remain issues. Quantitative neuromuscular monitoring to ensure complete reversal and adequate postoperative monitoring is strongly recommended in these patients, despite the use of sugammadex.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12871-019-0887-3","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T12:03:34Z","timestamp":1574165014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0336-872X","authenticated-orcid":false,"given":"Usha","family":"Gurunathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakeel Meeran","family":"Kunju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa May Lin","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"issue":"6","key":"887_CR1","doi-asserted-by":"publisher","DOI":"10.1117\/1.JBO.18.6.066017","volume":"18","author":"A Saez","year":"2013","unstructured":"Saez A, Acha B, Montero-Sanchez A, Rivas E, Escudero LM, Serrano C. Neuromuscular disease classification system. J Biomed Opt. 2013;18(6):066017.","journal-title":"J Biomed Opt"},{"issue":"3","key":"887_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/jnnp.2007.118810","volume":"79","author":"LJ Hauck","year":"2008","unstructured":"Hauck LJ, White C, Feasby TE, Zochodne DW, Svenson LW, Hill MD. Incidence of Guillain-Barre syndrome in Alberta, Canada: an administrative data study. J Neurol Neurosurg Psychiatry. 2008;79(3):318\u201320.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"887_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nmd.2015.10.009","volume":"26","author":"A Breiner","year":"2016","unstructured":"Breiner A, Widdifield J, Katzberg HD, Barnett C, Bril V, Tu K. Epidemiology of myasthenia gravis in Ontario, Canada. Neuromuscul Disord. 2016;26(1):41\u20136.","journal-title":"Neuromuscul Disord"},{"key":"887_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 2010;10:46.","journal-title":"BMC Neurol"},{"issue":"3","key":"887_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1213\/01.ane.0000244594.63318.fc","volume":"104","author":"M Naguib","year":"2007","unstructured":"Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg. 2007;104(3):575\u201381.","journal-title":"Anesth Analg"},{"issue":"2","key":"887_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/1521-3773(20020118)41:2<265::AID-ANIE265>3.0.CO;2-Q","volume":"41","author":"A Bom","year":"2002","unstructured":"Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, MacLean EJ, Muir AW, Palin R, Rees DC, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl. 2002;41(2):266\u201370.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"887_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/bja\/aep093","volume":"103","author":"A Srivastava","year":"2009","unstructured":"Srivastava A, Hunter JM. Reversal of neuromuscular block. Br J Anaesth. 2009;103(1):115\u201329.","journal-title":"Br J Anaesth"},{"issue":"1","key":"887_CR8","first-page":"57","volume":"15","author":"D Karalapillai","year":"2013","unstructured":"Karalapillai D, Kaufman M, Weinberg L. Sugammadex. Crit Care Res. 2013;15(1):57\u201362.","journal-title":"Crit Care Res"},{"issue":"4","key":"887_CR9","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1213\/ANE.0b013e3181ce8d5e","volume":"110","author":"A Abrishami","year":"2010","unstructured":"Abrishami A, Ho J, Wong J, Yin L, Chung F. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Anesth Analg. 2010;110(4):1239.","journal-title":"Anesth Analg"},{"issue":"1","key":"887_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tacc.2011.11.003","volume":"2","author":"SJA Gold","year":"2012","unstructured":"Gold SJA, Harper NJN. The place of sugammadex in anaesthesia practice. Trends Anaesth Crit Care. 2012;2(1):4\u20139.","journal-title":"Trends Anaesth Crit Care"},{"issue":"4","key":"887_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1177\/0310057X1103900429","volume":"39","author":"PA Stewart","year":"2011","unstructured":"Stewart PA, Phillips S, de Boer HD. Residual neuromuscular blockade in myotonic dystrophy: lessons unlearned and sugammadex. Anaesth Intensive Care. 2011;39(4):756\u20137.","journal-title":"Anaesth Intensive Care"},{"issue":"10","key":"887_CR12","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/EJA.0b013e3283392593","volume":"27","author":"AM Petrun","year":"2010","unstructured":"Petrun AM, Mekis D, Kamenik M. Successful use of rocuronium and sugammadex in a patient with myasthenia. Eur J Anaesthesiol. 2010;27(10):917\u20138.","journal-title":"Eur J Anaesthesiol"},{"issue":"4","key":"887_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.redar.2012.07.007","volume":"60","author":"PA Stewart","year":"2013","unstructured":"Stewart PA, Phillips S, De Boer HD. Sugammadex reversal of rocuronium-induced neuromuscular blockade in two types of neuromuscular disorders: Myotonic dystrophy and spinal muscular atrophy. Rev Esp Anestesiol Reanim. 2013;60(4):226\u20139.","journal-title":"Rev Esp Anestesiol Reanim"},{"issue":"4","key":"887_CR14","first-page":"419","volume":"79","author":"F Racca","year":"2013","unstructured":"Racca F, Mongini T, Wolfler A, Vianello A, Cutrera R, Del Sorbo L, Capello EC, Gregoretti C, Massa R, De Luca D, et al. Recommendations for anesthesia and perioperative management of patients with neuromuscular disorders. Minerva Anestesiol. 2013;79(4):419\u201333.","journal-title":"Minerva Anestesiol"},{"issue":"1","key":"887_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/aas.12419","volume":"59","author":"MV Madsen","year":"2015","unstructured":"Madsen MV, Staehr-Rye AK, Gatke MR, Claudius C. Neuromuscular blockade for optimising surgical conditions during abdominal and gynaecological surgery: a systematic review. Acta Anaesthesiol Scand. 2015;59(1):1\u201316.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"8","key":"887_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/EJA.0000000000000094","volume":"31","author":"PE Dubois","year":"2014","unstructured":"Dubois PE, Putz L, Jamart J, Marotta ML, Gourdin M, Donnez O. Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. Eur J Anaesthesiol. 2014;31(8):430\u20136.","journal-title":"Eur J Anaesthesiol"},{"issue":"Suppl 1","key":"887_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2044.2008.05873.x","volume":"64","author":"C Lee","year":"2009","unstructured":"Lee C. Goodbye suxamethonium! Anaesthesia. 2009;64(Suppl 1):73\u201381.","journal-title":"Anaesthesia"},{"issue":"2","key":"887_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/bja\/54.2.195","volume":"54","author":"NN Durant","year":"1982","unstructured":"Durant NN, Katz RL. Suxamethonium. Br J Anaesth. 1982;54(2):195\u2013208.","journal-title":"Br J Anaesth"},{"issue":"4","key":"887_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/bja\/aem213","volume":"99","author":"C Claudius","year":"2007","unstructured":"Claudius C, Karacan H, Viby-Mogensen J. Prolonged residual paralysis after a single intubating dose of rocuronium. Br J Anaesth. 2007;99(4):514\u20137.","journal-title":"Br J Anaesth"},{"issue":"3","key":"887_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.aat.2014.02.005","volume":"52","author":"T Shimauchi","year":"2014","unstructured":"Shimauchi T, Yamaura K, Sugibe S, Hoka S. Usefulness of sugammadex in a patient with Becker muscular dystrophy and dilated cardiomyopathy. Acta Anaesthesiol Taiwanica. 2014;52(3):146\u20138.","journal-title":"Acta Anaesthesiol Taiwanica"},{"issue":"5","key":"887_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/bja\/54.5.529","volume":"54","author":"W Buzello","year":"1982","unstructured":"Buzello W, Krieg N, Schlickewei A. Hazards of neostigmine in patients with neuromuscular disorders. Report of two cases. Br J Anaesth. 1982;54(5):529\u201334.","journal-title":"Br J Anaesth"},{"issue":"4","key":"887_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/MJT.0b013e31817fe2d7","volume":"16","author":"WH Ren","year":"2009","unstructured":"Ren WH, Jahr JS. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex. Am J Ther. 2009;16(4):295\u20139.","journal-title":"Am J Ther"},{"issue":"5","key":"887_CR23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/anae.14160","volume":"73","author":"AM Hristovska","year":"2018","unstructured":"Hristovska AM, Duch P, Allingstrup M, Afshari A. The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis. Anaesthesia. 2018;73(5):631\u201341.","journal-title":"Anaesthesia"},{"issue":"9","key":"887_CR24","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/j.1365-2044.1987.tb05365.x","volume":"42","author":"AP Wainwright","year":"1987","unstructured":"Wainwright AP, Brodrick PM. Suxamethonium in myasthenia gravis. Anaesthesia. 1987;42(9):950\u20137.","journal-title":"Anaesthesia"},{"issue":"3","key":"887_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/BF03005579","volume":"37","author":"JB Eisenkraft","year":"1990","unstructured":"Eisenkraft JB, Book WJ, Papatestas AE. Sensitivity to vecuronium in myasthenia gravis: a dose-response study. Can J Anaesth. 1990;37(3):301\u20136.","journal-title":"Can J Anaesth"},{"issue":"9","key":"887_CR26","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/aas.12391","volume":"58","author":"P Casarotti","year":"2014","unstructured":"Casarotti P, Mendola C, Cammarota G, Della Corte F. High-dose rocuronium for rapid-sequence induction and reversal with sugammadex in two myasthenic patients. Acta Anaesthesiol Scand. 2014;58(9):1154\u20138.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"887_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1399-6576.2011.02558.x","volume":"56","author":"L Blichfeldt-Lauridsen","year":"2012","unstructured":"Blichfeldt-Lauridsen L, Hansen BD. Anesthesia and myasthenia gravis. Acta Anaesthesiol Scand. 2012;56(1):17\u201322.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"887_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/ACO.0000000000000272","volume":"29","author":"Z Sungur","year":"2016","unstructured":"Sungur Z, Senturk M. Anaesthesia for thymectomy in adult and juvenile myasthenic patients. Curr Opin Anaesthesiol. 2016;29(1):14\u20139.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"6","key":"887_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2044.2010.06360.x","volume":"65","author":"HD De Boer","year":"2010","unstructured":"De Boer HD, Van Egmond J, Driessen JJ, Booij LHJD. Sugammadex in patients with myasthenia gravis: correspondence. Anaesthesia. 2010;65(6):653.","journal-title":"Anaesthesia"},{"key":"887_CR30","doi-asserted-by":"publisher","unstructured":"Mouri H, Jo T, Matsui H, Fushimi K, Yasunaga H. Effect of Sugammadex on postoperative Myasthenic crisis in myasthenia gravis patients: propensity score analysis of a Japanese Nationwide database. Anesth Analg. 2019. https:\/\/doi.org\/10.1213\/ANE.0000000000004239. Epub ahead of print.","DOI":"10.1213\/ANE.0000000000004239"},{"issue":"6","key":"887_CR31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/aas.12123","volume":"57","author":"Z Sungur Ulke","year":"2013","unstructured":"Sungur Ulke Z, Yavru A, Camci E, Ozkan B, Toker A, Senturk M. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy. Acta Anaesthesiol Scand. 2013;57(6):745\u20138.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"887_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ijoa.2012.02.006","volume":"21","author":"V Garcia","year":"2012","unstructured":"Garcia V, Diemunsch P, Boet S. Use of rocuronium and sugammadex for caesarean delivery in a patient with myasthenia gravis. Int J Obstet Anesth. 2012;21(3):286\u20137.","journal-title":"Int J Obstet Anesth"},{"key":"887_CR33","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2147\/TCRM.S93009","volume":"11","author":"T Vymazal","year":"2015","unstructured":"Vymazal T, Krecmerova M, Bicek V, Lischke R. Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery - a series of 117 cases. Ther Clin Risk Manag. 2015;11:1593\u20136.","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"887_CR34","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/bja\/aet098","volume":"110","author":"G Kiss","year":"2013","unstructured":"Kiss G, Lacour A, d'Hollander A. Fade of train-of-four ratio despite administration of more than 12 mg kg (\u22121) sugammadex in a myasthenia gravis patient receiving rocuronium. Br J Anaesth. 2013;110(5):854\u20135.","journal-title":"Br J Anaesth"},{"issue":"3","key":"887_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/ACC.0b013e3182953053","volume":"1","author":"Y Sugi","year":"2013","unstructured":"Sugi Y, Nitahara K, Shiroshita T, Higa K. Restoration of train-of-four ratio with neostigmine after insufficient recovery with Sugammadex in a patient with myasthenia gravis. A A Case Rep. 2013;1(3):43\u20135.","journal-title":"A A Case Rep"},{"key":"887_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00003643-201306001-00080","volume":"30","author":"RA O'Leary","year":"2013","unstructured":"O'Leary RA, C MC. Stopped short: Sugammadex in undiagnosed Myasthenia gravis [Conference Abstract]. Eur J Anaesthesiol. 2013;30:26.","journal-title":"Eur J Anaesthesiol"},{"issue":"12","key":"887_CR37","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1007\/s12630-013-0042-4","volume":"60","author":"H Iwasaki","year":"2013","unstructured":"Iwasaki H, Takahoko K, Otomo S, Sasakawa T, Kunisawa T, Iwasaki H. Monitoring of neuromuscular blockade in one muscle group alone may not reflect recovery of total muscle function in patients with ocular myasthenia gravis. Can J Anaesth. 2013;60(12):1222\u20137.","journal-title":"Can J Anaesth"},{"issue":"22","key":"887_CR38","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2011.1794","volume":"306","author":"AR Punnoose","year":"2011","unstructured":"Punnoose AR, Burke AE, Golub RM. JAMA patient page. Muscular dystrophy. JAMA. 2011;306(22):2526.","journal-title":"JAMA"},{"key":"887_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jns.2016.07.036","volume":"368","author":"T Matsumura","year":"2016","unstructured":"Matsumura T, Saito T, Yonemoto N, Nakamori M, Sugiura T, Nakamori A, Fujimura H, Sakoda S. Renal dysfunction can be a common complication in patients with myotonic dystrophy 1. J Neurol Sci. 2016;368:266\u201371.","journal-title":"J Neurol Sci"},{"issue":"10","key":"887_CR40","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/bja\/39.10.815","volume":"39","author":"RE Thiel","year":"1967","unstructured":"Thiel RE. The myotonic response to suxamethonium. Br J Anaesth. 1967;39(10):815\u201321.","journal-title":"Br J Anaesth"},{"issue":"2","key":"887_CR41","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/bja\/72.2.210","volume":"72","author":"SH Russell","year":"1994","unstructured":"Russell SH, Hirsch NP. Anaesthesia and myotonia. Br J Anaesth. 1994;72(2):210\u20136.","journal-title":"Br J Anaesth"},{"issue":"1","key":"887_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0310057X0102900106","volume":"29","author":"AR Imison","year":"2001","unstructured":"Imison AR. Anaesthesia and myotonia--an Australian experience. Anaesth Intensive Care. 2001;29(1):34\u20137.","journal-title":"Anaesth Intensive Care"},{"key":"887_CR43","first-page":"680568","volume":"2014","author":"AA Wefki Abdelgawwad Shousha","year":"2014","unstructured":"Wefki Abdelgawwad Shousha AA, Sanfilippo M, Sabba A, Pinchera P. Sugammadex and reversal of neuromuscular block in adult patient with duchenne muscular dystrophy. Case Rep Anesthesiol. 2014;2014:680568.","journal-title":"Case Rep Anesthesiol"},{"issue":"5","key":"887_CR44","first-page":"959","volume":"38","author":"P Baumgartner","year":"2010","unstructured":"Baumgartner P, Baumgartner P. Rocuronium and sugammadex in myotonic dystrophy. Anaesth Intensive Care. 2010;38(5):959\u201360.","journal-title":"Anaesth Intensive Care"},{"issue":"2","key":"887_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/EJA.0b013e3283405b87","volume":"28","author":"Y Matsuki","year":"2011","unstructured":"Matsuki Y, Hirose M, Tabata M, Nobukawa Y, Shigemi K. The use of sugammadex in a patient with myotonic dystrophy. Euro J Anaesth. 2011;28(2):145\u20136.","journal-title":"Euro J Anaesth"},{"issue":"2","key":"887_CR46","first-page":"101","volume":"62","author":"P Mavridou","year":"2011","unstructured":"Mavridou P, Dimitriou V, Margaritis A, Manataki A. Anesthesia for laparoscopic surgery in a patient with myotonic dystrophy (Steinert's disease): beneficial use of sugammadex, but incorrect use of pethidine: a case report. Acta Anaesthesiol Belg. 2011;62(2):101\u20134.","journal-title":"Acta Anaesthesiol Belg"},{"issue":"3","key":"887_CR47","first-page":"505","volume":"39","author":"J Petrovski","year":"2011","unstructured":"Petrovski J. The use of sugammadex to reverse rocuronium in a patient with myotonic dystrophy. Anaesth Intensive Care. 2011;39(3):505\u20136.","journal-title":"Anaesth Intensive Care"},{"issue":"10","key":"887_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/1750458919838412","volume":"29","author":"J Teixeira","year":"2019","unstructured":"Teixeira J, Matias B, Ferreira I, Tale\u00e7o T, Duarte JS. Sugammadex is changing the paradigm in neuromuscular blockade in patients with myotonic dystrophy. J Perioper Pract. 2019;29(10):337\u201340.","journal-title":"J Perioper Pract"},{"key":"887_CR49","first-page":"4282305","volume":"2019","author":"C Mangla","year":"2019","unstructured":"Mangla C, Bais K, Yarmush J. Myotonic dystrophy and anesthetic challenges: a case report and review. Case Rep Anesthesiol. 2019;2019:4282305.","journal-title":"Case Rep Anesthesiol"},{"key":"887_CR50","first-page":"107952","volume":"2012","author":"A Kashiwai","year":"2012","unstructured":"Kashiwai A, Suzuki T, Ogawa S. Sensitivity to rocuronium-induced neuromuscular block and reversibility with sugammadex in a patient with myotonic dystrophy. Case Rep Anesthesiol. 2012;2012:107952.","journal-title":"Case Rep Anesthesiol"},{"issue":"4","key":"887_CR51","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/bja\/aet037","volume":"110","author":"P Stourac","year":"2013","unstructured":"Stourac P, Krikava I, Seidlova J, Strazevska E, Huser M, Hruban L, Janku P, Gal R. Sugammadex in a parturient with myotonic dystrophy. Br J Anaesth. 2013;110(4):657\u20138.","journal-title":"Br J Anaesth"},{"issue":"7","key":"887_CR52","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/EJA.0000000000000442","volume":"33","author":"M Kosinova","year":"2016","unstructured":"Kosinova M, Stourac P, Harazim H, Janku P, Huser M, Vohanka S. Anaesthesia and orphan disease: rocuronium and sugammadex in the anaesthetic management of a parturient with Becker's myotonia congenita. Euro J Anaesthesiol. 2016;33(7):545\u20137.","journal-title":"Euro J Anaesthesiol"},{"issue":"5","key":"887_CR53","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jclinane.2015.03.011","volume":"27","author":"P Kendigelen","year":"2015","unstructured":"Kendigelen P, Tutuncu AC, Ashyralyyeva G, Hamamcioglu EA, Kaya G. Sugammadex usage in a patient with dermatomyositis. J Clin Anesth. 2015;27(5):438\u20139.","journal-title":"J Clin Anesth"},{"issue":"4","key":"887_CR54","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/bja\/aes087","volume":"108","author":"T Suzuki","year":"2012","unstructured":"Suzuki T, Nameki K, Shimizu H, Shimizu Y, Nakamura R, Ogawa S. Efficacy of rocuronium and sugammadex in a patient with dermatomyositis. Br J Anaesth. 2012;108(4):703.","journal-title":"Br J Anaesth"},{"issue":"4","key":"887_CR55","doi-asserted-by":"publisher","first-page":"472","DOI":"10.4103\/sja.SJA_625_16","volume":"11","author":"C Staikou","year":"2017","unstructured":"Staikou C, Rekatsina M. Use of rocuronium and sugammadex under neuromuscular transmission monitoring in a patient with multiple sclerosis. Saudi J Anaesth. 2017;11(4):472\u20135.","journal-title":"Saudi J Anaesth"},{"issue":"3","key":"887_CR56","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijoa.2010.03.009","volume":"19","author":"G Weekes","year":"2010","unstructured":"Weekes G, Hayes N, Bowen M. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis. Int J Obstet Anesth. 2010;19(3):333\u20136.","journal-title":"Int J Obstet Anesth"},{"issue":"5 Peripheral Ne","key":"887_CR57","first-page":"1185","volume":"20","author":"E Tiryaki","year":"2014","unstructured":"Tiryaki E, Horak HA. ALS and other motor neuron diseases. Continuum (Minneap Minn). 2014;20(5 Peripheral Nervous System Disorders):1185\u2013207.","journal-title":"Continuum (Minneap Minn)"},{"issue":"3","key":"887_CR58","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000343168","volume":"22","author":"E Kelsaka","year":"2013","unstructured":"Kelsaka E, Karakaya D, Zengin EC. Use of sugammadex in a patient with amyotrophic lateral sclerosis. Med Princ Pract. 2013;22(3):304\u20136.","journal-title":"Med Princ Pract"},{"issue":"2","key":"887_CR59","first-page":"125","volume":"68","author":"YJ Chang","year":"2014","unstructured":"Chang YJ, Jung WS, Son WR, Jo YY. Discordance between train-of-four response and clinical symptoms in a patient with amyotrophic lateral sclerosis. Acta Med Okayama. 2014;68(2):125\u20137.","journal-title":"Acta Med Okayama"},{"issue":"4","key":"887_CR60","first-page":"475","volume":"21","author":"TB Chang","year":"2017","unstructured":"Chang TB, Huh J. Delayed neuromuscular recovery after use of sugammadex in a patient with amyotrophic lateral sclerosis: a case report. Anaesth Pain Intensive Care. 2017;21(4):475\u20138.","journal-title":"Anaesth Pain Intensive Care"},{"issue":"3","key":"887_CR61","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000343168","volume":"22","author":"E Kelsaka","year":"2013","unstructured":"Kelsaka E, Karakaya D, Zengin EC, Zengin EC. Use of sugammadex in a patient with amyotrophic lateral sclerosis. Med Principles Pract. 2013;22(3):304\u20136.","journal-title":"Med Principles Pract"},{"issue":"3","key":"887_CR62","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1399-6576.2011.02395.x","volume":"55","author":"T Suzuki","year":"2011","unstructured":"Suzuki T. A train-of-four ratio of 0.9 may not certify adequate recovery after sugammadex. Acta Anaesthesiol Scand. 2011;55(3):368\u20139.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"23","key":"887_CR63","first-page":"e7098","volume":"96","author":"JH Yoo","year":"2017","unstructured":"Yoo JH, Kim SI, Park SY, Jun MR, Kim YE, Kim HJ. Use of sugammadex in a patient with progressive muscular atrophy and in a patient with amyotrophic lateral sclerosis. Medicine (United States). 2017;96(23):e7098.","journal-title":"Medicine (United States)"},{"issue":"4","key":"887_CR64","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1212\/01.WNL.0000151978.74467.E7","volume":"64","author":"AD Sperfeld","year":"2005","unstructured":"Sperfeld AD, Hanemann CO, Ludolph AC, Kassubek J. Laryngospasm: an underdiagnosed symptom of X-linked spinobulbar muscular atrophy. Neurology. 2005;64(4):753\u20134.","journal-title":"Neurology"},{"issue":"3","key":"887_CR65","doi-asserted-by":"publisher","first-page":"418","DOI":"10.4103\/1658-354X.136640","volume":"8","author":"R Takeuchi","year":"2014","unstructured":"Takeuchi R, Hoshijima H, Doi K, Nagasaka H. The use of sugammadex in a patient with Kennedy's disease under general anesthesia. Saudi J Anaesth. 2014;8(3):418\u201320.","journal-title":"Saudi J Anaesth"},{"issue":"2","key":"887_CR66","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00540-011-1308-z","volume":"26","author":"H Vilela","year":"2012","unstructured":"Vilela H, Santos J, Cola\u00e7o J, Oliveira E, Canas-da-Silva P. Reversal of neuromuscular blockade with sugammadex in a patient with spinal muscular atrophy type III (Kugelberg-Welander syndrome). J Anesth. 2012;26(2):306\u20137.","journal-title":"J Anesth"},{"issue":"4","key":"887_CR67","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/bja\/ael013","volume":"96","author":"HD de Boer","year":"2006","unstructured":"de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LH. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized rhesus monkey. Br J Anaesth. 2006;96(4):473\u20139.","journal-title":"Br J Anaesth"},{"issue":"2","key":"887_CR68","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/ALN.0b013e3182065c36","volume":"114","author":"DL McDonagh","year":"2011","unstructured":"McDonagh DL, Benedict PE, Kovac AL, Drover DR, Brister NW, Morte JB, Monk TG. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients. Anesthesiology. 2011;114(2):318\u201329.","journal-title":"Anesthesiology"},{"issue":"1","key":"887_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1399-6576.2011.02589.x","volume":"56","author":"F Yoshida","year":"2012","unstructured":"Yoshida F, Suzuki T, Kashiwai A, Furuya T, Konishi J, Ogawa S. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex. Acta Anaesthesiol Scand. 2012;56(1):83\u20137.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"6","key":"887_CR70","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1177\/0310057X1204000611","volume":"40","author":"GV Cammu","year":"2012","unstructured":"Cammu GV, Smet V, De Jongh K, Vandeput D. A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery. Anaesth Intensive Care. 2012;40(6):999\u20131006.","journal-title":"Anaesth Intensive Care"},{"issue":"3","key":"887_CR71","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1213\/01.ane.0000250617.79166.7f","volume":"104","author":"DJ Eleveld","year":"2007","unstructured":"Eleveld DJ, Kuizenga K, Proost JH, Wierda JM. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex. Anesth Analg. 2007;104(3):582\u20134.","journal-title":"Anesth Analg"},{"issue":"suppl_1","key":"887_CR72","doi-asserted-by":"publisher","first-page":"i53","DOI":"10.1093\/bja\/aex318","volume":"119","author":"JM Hunter","year":"2017","unstructured":"Hunter JM. Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation. Br J Anaesth. 2017;119(suppl_1):i53\u201362.","journal-title":"Br J Anaesth"},{"issue":"3","key":"887_CR73","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2044.2010.06611.x","volume":"66","author":"L Men\u00e9ndez-Ozcoidi","year":"2011","unstructured":"Men\u00e9ndez-Ozcoidi L, Ortiz-G\u00f3mez JR, Olaguibel-Ribero JM, Salvador-Bravo MJ. Allergy to low dose sugammadex. Anaesthesia. 2011;66(3):217\u2013219 213.","journal-title":"Anaesthesia"},{"issue":"12","key":"887_CR74","first-page":"291","volume":"40","author":"T Takahiro","year":"2012","unstructured":"Takahiro T, Haruyama N, Mae T, Doi K, Ozaki M. Be careful about anaphylactic shock by antagonism of the neuromuscular blockade \u223ccases of anaphylactic shock induced by Sugammadex. Crit Care Med. 2012;40(12):291.","journal-title":"Crit Care Med"},{"key":"887_CR75","unstructured":"Merck Sharp and Dohme (Australia) [www.medsafe.govt.nz\/profs\/datasheet\/b\/briodionini.pdf]."},{"issue":"3","key":"887_CR76","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/bja\/aes207","volume":"109","author":"G Cammu","year":"2012","unstructured":"Cammu G, Van Vlem B, van den Heuvel M, Stet L, el Galta R, Eloot S, Demeyer I. Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment. Br J Anaesth. 2012;109(3):382\u201390.","journal-title":"Br J Anaesth"},{"key":"887_CR77","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/1756-0500-7-264","volume":"7","author":"T Nissen","year":"2014","unstructured":"Nissen T, Wynn R. The clinical case report: a review of its merits and limitations. BMC Res Notes. 2014;7:264.","journal-title":"BMC Res Notes"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-019-0887-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12871-019-0887-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-019-0887-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T03:21:57Z","timestamp":1665026517000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-019-0887-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1186\/s12871-019-0887-3","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,19]]},"assertion":[{"value":"27 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"U. G, S. K and L. S have been sponsored by Merck, Sharp & Dohme (MSD) to participate in the MSD conferences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"213"}}